Sequential ATR and PARP Inhibition Overcomes Acquired DNA Damaging Agent Resistance in Pancreatic Ductal Adenocarcinoma
Katharine J. Herbert, Rosanna Upstill‐Goddard, Stephan B. Dreyer, Selma Rebus, Australian Pancreatic Cancer Genome Initiative, Christian P. Pilarsky, Debabrata Mukhopadhyay, Christopher J. Lord, Genomics Innovation Alliance, Andrew Victor Biankin, Fieke E. M. Froeling, David Kuang-Fu Chang
This study shows that sequential ATR and PARP inhibition can overcome acquired resistance to DNA damaging agents in pancreatic ductal adenocarcinoma.
British Journal of Cancer · May 29, 2025Peer-reviewedCancer Biology